A multicenter study of anaplastic oligodendroglioma: the Korean Radiation Oncology Group Study 13

A multicenter study of anaplastic oligodendroglioma: the Korean Radiation Oncology Group Study 13–12

Published:2015-09-04 Issue:1 Volume:125 Page:207-215
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Kang Hyun-Cheol,Yu Tosol,Lim Do Hoon,Kim Il Han,Chung Woong-Ki,Suh Chang-Ok,Choi Byung Ock,Cho Kwan Ho,Cho Jae Ho,Kim Jin Hee,Nam Do-Hyun,Park Chul-Kee,Hong Yong-Kil,Kim In Ah

Funder

Korean Radiation Oncology Group and Cancer Control Program from the Korean Ministry of Health & Welfare

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Clinical Neurology,Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11060-015-1902-2.pdf

Reference33 articles.

1. van den Bent MJ, Kros JM, Heimans JJ et al (1998) Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology Group. Neurology 51:1140–1145

2. Paleologos NA, Macdonald DR, Vick NA, Cairncross JG (1999) Neoadjuvant procarbazine, CCNU, and vincristine for anaplastic and aggressive oligodendroglioma. Neurology 53:1141–1143

3. Smith JS, Perry A, Borell TJ et al (2000) Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 18:636–645

4. Brandes AA, Tosoni A, Vastola F et al (2004) Efficacy and feasibility of standard procarbazine, lomustine, and vincristine chemotherapy in anaplastic oligodendroglioma and oligoastrocytoma recurrent after radiotherapy. A Phase II study. Cancer 101:2079–2085

5. Cairncross G, Wang M, Shaw E et al (2013) Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol 31:337–343

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review and meta-analysis informing the role of adjuvant radiotherapy (RT) in Grade 2 and 3 oligodendroglioma;Journal of Clinical Neuroscience;2024-08

2. Characteristics of Anaplastic Oligodendrogliomas Short-Term Survivors: A POLA Network Study;The Oncologist;2022-03-05

3. Survival outcome and prognostic factors in anaplastic oligodendroglioma: a single-institution study of 95 cases;Scientific Reports;2020-11-19